|
시장보고서
상품코드
2084764
샤르코-마리-투스병 시장 : 질환 유형별, 약제 유형별, 유통 채널별, 지역별Charcot-Marie-Tooth Disease Market, By Disease Type, By Drug Type, By Distribution Channel, By Geography |
||||||
샤르코-마리-투스병 시장 규모는 2026년에 22억 7,150만 달러로 추정되고 있으며, 2033년까지 98억 9,650만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 23.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 22억 7,150만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 23.40% | 2033년 시장 규모 예측 : | 98억 9,650만 달러 |
샤르코-마리-투스(CMT) 병은 운동 및 감각을 담당하는 말초신경의 구조와 기능에 영향을 미치는 유전자 변이로 인해 발생합니다. 결함이 있는 유전자는 말초신경 내의 신경섬유(축삭)나 미엘린 수초(신경섬유를 감싸는 지방층)의 변성을 유발할 가능성이 있습니다. 이로 인해 뇌와 사지 간의 신경 신호 전달이 약화되어 근육 위축이나 감각 저하를 초래합니다. 샤르코-마리-투스병이 진행됨에 따라 증상은 발과 다리에서 손과 팔로 퍼져 나갑니다.
증상의 중증도(다리, 발목, 발의 근력 저하, 교량과 발의 근육량 감소, 높은 발바닥 아치, 발가락이 구부러지는 증상(해머토우), 보행 및 달리기 능력 저하 등이 포함됩니다)는 가족 내에서도 사람마다 다릅니다. CMT의 다양한 유형과 아형은 변이 유전자, 유전자형, 신경전도 속도, 발병 연령, 질환의 중증도, 임상 증상 및 말초신경 손상을 바탕으로 결정됩니다. CMT의 다양한 유형에는 CMT1, CMT2, CMT3, CMT4, CMTX 및 DICMT가 포함됩니다.
시장 역학
샤르코-마리-투스병의 유병률 증가는 시장 성장을 이끄는 주요 요인 중 하나입니다. 예를 들어 2021년 1월 Medscape가 발표한 자료에 따르면 CMT의 유병률은 인구 2,500명당 1명이며, 미국에서는 약 12만 5,000명에 해당합니다. CMT 1의 발생률은 인구 10만 명당 15명이며, CMT 1A의 유병률은 인구 10만 명당 10.5명으로, 이는 CMT 1 전체의 70%에 해당합니다. CMT 2의 유병률은 인구 10만 명당 7명입니다. CMT X 환자는 전체 CMT 증후군 환자의 최소 10-20%를 차지합니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 시장 전략)를 바탕으로 전 세계 샤르코-마리-투스병 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 이 '세계의 샤르코-마리-투스병 시장 보고서'는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 샤르코-마리-투스병 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 세계의 샤르코-마리-투스병 시장 인사이트
제4장 세계의 샤르코-마리-투스병 시장 : 질환 유형별, 2021-2033년
제5장 세계의 샤르코-마리-투스병 시장 : 약제 유형별, 2021-2033년
제6장 세계의 샤르코-마리-투스병 시장 : 유통 채널별, 2021-2033년
제7장 세계의 샤르코-마리-투스병 시장 : 지역별, 2021-2033년
제8장 경쟁 스냅숏
제9장 섹션
KSA 26.07.14Charcot-Marie-Tooth Disease Market is estimated to be valued at USD 2,271.5 Mn in 2026 and is expected to reach USD 9,896.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 23.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2,271.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 23.40% | 2033 Value Projection: | USD 9,896.5 Mn |
Charcot-marie-tooth (CMT) disease is caused by mutations in the genes that affect the structure and function of peripheral nerves that control movement and sensation. Defective genes can cause the nerve fibers (axons) or myelin sheaths (the fat layer that separates nerve fibers) to degenerate in the peripheral nerves. This weakens the transmission of nerve signals between the brain and limbs, causing muscle atrophy and decreased sensation. As charcot-marie-tooth disease progresses, symptoms will spread from the feet and legs to the hands and arms.
The severity of symptoms (that includes weakness in the legs, ankles, and feet, decreased muscle mass in the legs and feet, high foot arches, curled toes (hammer toes), and decreased walking and running ability, among others) varies from person to person, including between family members. The different types and subtypes of CMT are determined based on the mutant gene, genetic type, nerve conduction velocity, age of onset, disease severity, clinical symptoms, and peripheral nerve injury. The different types of CMT diseases include CMT1, CMT2, CMT3, CMT4, CMTX, and DICMT.
Market Dynamics
Increasing prevalence of charcot-marie tooth disease is one major factor driving the market growth. For instance, according to a data published by the Medscape in January 2021, the prevalence of CMT disease is one in 2,500 population, which is approximately 125,000 people in the U.S. The incidence of CMT 1 is 15 per 100,000 population; the incidence of CMT 1A is 10.5 per 100,000 population, or 70% of CMT 1. The incidence of CMT 2 is seven per 100,000 people. CMT X patients account for at least 10-20% of CMT syndrome patients.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global charcot-marie-tooth disease market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
- Key companies covered as a part of this study include Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp, Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global charcot-marie-tooth disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global charcot-marie-tooth disease market
Market Segmentation
- By Disease Type Insights (Revenue, USD Mn, 2021 - 2033)
- CMT 1
- CMT 2
- CMT 3
- Others
- By Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Nonsteroidal anti-inflammatory drugs
- Cyclooxygenase-2 inhibitors
- Tricyclic antidepressants
- Anticonvulsants
- Analgesics
- Pipeline Drug
- By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
- Key Players
- Addex Therapeutics Ltd.
- Affectis Pharmaceuticals AG
- Genzyme Corp
- Lead Discovery Center GmbH
- Pharnext SA
- Acceleron Pharma
- MedDay Pharmaceuticals
- Bristol-Myers-Squibb Company
- Inflectis Bio Science Health Company
- Helixmith Co., Ltd.
- Neurogene Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Opportunity Map
3. Global Charcot-Marie-Tooth Disease Market Insights
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Pipeline Analysis
- Market Trends
- Product Launches
- Key Developments
- Regulatory Scenario
- Collaborations & Acquisitions
- Epidemiology
- PEST Analysis
4. Global Charcot-Marie-Tooth Disease Market, By Disease Type, 2021 - 2033 (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- CMT 1
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- CMT 2
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- CMT 3
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
5. Global Charcot-Marie-Tooth Disease Market, By Drug Type, 2021 - 2033 (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Nonsteroidal anti-inflammatory drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- Cyclooxygenase-2 inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- Tricyclic antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- Pipeline Drug
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
6. Global Charcot-Marie-Tooth Disease Market, By Distribution Channel, 2021 - 2033 (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
7. Global Charcot-Marie-Tooth Disease Market, By Region, 2021 - 2033 (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Region at Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Million)
- South Africa
- Central Africa
- North Africa
8. Competitive Snapshot
- Company Profiles
- Addex Therapeutics Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Affectis Pharmaceuticals AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genzyme Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lead Discovery Center GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharnext SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Acceleron Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MedDay Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers-Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Inflectis Bio Science Health Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Helixmith Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Neurogene Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Addex Therapeutics Ltd.
9. Section
- Research Methodology
- About us
